Potential New Stem Cell Treatment for Scleroderma Uncovered

Wendy Henderson avatar

by Wendy Henderson |

Share this article:

Share article via email


In this video from Wochit News, researchers at the Hospital for Special Surgery in New York City have found what could be a potential new stem cell treatment to help slow down skin fibrosis in scleroderma patients.

A review finds plasma exchange is an effective therapy for Raynaud’s and digital ulcers.

The study using mouse models found that by injecting scleroderma-infected mice with adipose-derived stromal cells (ADSCs) the fibrosis was reduced. It is hoped that this treatment could be used in humans to reduce or reverse skin damage caused by scleroderma and that in the future the treatment could also be applied to other autoimmune diseases such as lupus and rheumatoid arthritis. Find out more about the study here.

Scleroderma patients may prevent pulmonary arterial hypertension with long-term Tracleer treatment. 

Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.